WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

Video Credit: Wibbitz Top Stories
Published on May 27, 2020 - Duration: 01:30s

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 The move comes after a report linked the drug to an increased fatality rate among those with coronavirus.

The study in medical journal 'The Lancet' adds that it can increase odds of heart failure in coronavirus patients.

The decision has been confirmed by World Health Organization director-general Tedros Adhanom Ghebreyesus.

Tedros Adhanom Ghebreyesus WHO chief scientist Soumya Swaminathan adds that more research on hydroxychloroquine is needed.

Soumya Swaminathan Further trials conducted in the U.S. and France claim hydroxychloroquine won't help battle the pandemic.

Hydroxychloroquine can help treat malaria and lupus, but its effectiveness against COVID-19 remains unknown.

President Donald Trump has often claimed that hydroxychloroquine is useful against the coronavirus.

Trump even recently said that he was personally taking the drug as a precaution.


You are here

Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine 00:32
Video credit: Wochit Entertainment - Published on May 31, 2020 

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct 03:14
Video credit: HT Digital Content - Published on May 30, 2020 

World Health Organization Halts Trials Of Hydroxychloroquine 00:38
Video credit: Wochit - Published on May 26, 2020 

You might like